European Archives - Page 21 of 1486 - European Medical Journal

TNBC Study Identifies Drug Resistant Cell States

Researchers identified persistent drug tolerant cell states in TNBC that survive chemotherapy and may drive metastatic progression and treatment resistance.

Rural Hepatocellular Carcinoma Rates Rise as Urban Trends Decline

Rural HCC incidence increased between 2001 and 2022 while urban rates declined, highlighting widening disparities in liver cancer care.

Image-guided Cryoablation Cuts Pain in Umbilical Endometriosis

Percutaneous cryoablation reduced pain and lesion volume in women with umbilical endometriosis in a small single-centre study.

AI-Enhanced ECG Predicts Future Cardiac Arrest Risk

AI-Enhanced ECG Predicts Future Cardiac Arrest Risk

AI-enhanced ECG combined with electronic health records identified individuals at elevated risk of future out-of-hospital cardiac arrest

Early-Onset Kidney Stones Linked to Metabolic Disease Risk

Early-Onset Kidney Stones Linked to Metabolic Disease Risk

Early-onset kidney stone disease was linked to higher rates of metabolic and cardiovascular comorbidities in a cohort study of 546 patients.

CRISPR Edited AML Transplant Shows Safe Engraftment

CRISPR Edited AML Transplant Shows Safe Engraftment

A gene edited AML transplant strategy achieved rapid engraftment and supported targeted maintenance therapy without prolonged high grade cytopenias in high risk disease.

Slow Peanut Oral Immunotherapy Effective and Safe in Preschool Children

Slow Peanut Oral Immunotherapy Effective and Safe in Toddlers

Slow up-dosing peanut oral immunotherapy helped most preschool children achieve sustained unresponsiveness with few severe reactions.

MHRA launches UK-wide gene therapy consultation

The MHRA has launched a consultation calling to update the legal definition of gene therapy medicinal products.

Gut Microbiota Biomarkers in Diabetes with Heart Disease - EMJ

Gut Microbiota Biomarkers Identified in Diabetes with Heart Disease

Researchers identified distinct gut microbiota and metabolomic signatures associated with type 2 diabetes mellitus and coronary atherosclerotic heart disease.

Tofacitinib Supports Growth in JIA - EMJ

Tofacitinib Supports Growth in Juvenile Idiopathic Arthritis

Long-term tofacitinib treatment in juvenile idiopathic arthritis was associated with normal growth and stable hormone biomarkers.